TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4+T Cells
- 10 August 2021
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 95 (17) , JVI0081621
Abstract
Multiplein vivostudies showed that many LRAs used in the shock-and-kill approach could activate viral transcription but could not induce killing effectively. Therefore, a dual-function LRA is needed for elimination of HIV-1 reservoirs.Keywords
Funding Information
- MOST | National Science and Technology Infrastructure Program (2018ZX10301101)
- National Natural Science Foundation of China (81773787)
- People’s Government of Guangdong Province | National Natural Science Foundation of China-Guangdong Joint Fund (2018030312010)
This publication has 47 references indexed in Scilit:
- HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responsesCell Host & Microbe, 2021
- PIRs mediate innate myeloid cell memory to nonself MHC moleculesScience, 2020
- The HIV Reservoir in Monocytes and MacrophagesFrontiers in Immunology, 2019
- HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapyNature Microbiology, 2019
- Targeting the Latent Reservoir for HIV-1Immunity, 2018
- Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4 + T CellsJournal of Virology, 2014
- Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral TherapyPLOS Pathogens, 2014
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThe Lancet HIV, 2014
- Beyond Stem Cells: Self-Renewal of Differentiated MacrophagesScience, 2013
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyNature, 2012